{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:37:19Z","timestamp":1792813039797,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2504,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.bbmt.2008.03.005","type":"journal-article","created":{"date-parts":[[2008,5,18]],"date-time":"2008-05-18T04:08:08Z","timestamp":1211083688000},"page":"641-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1804,"title":["HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide"],"prefix":"10.1016","volume":"14","author":[{"given":"Leo","family":"Luznik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen R.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Susan","family":"Leffell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Zahurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted A.","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Piantadosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Kaup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Ann","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Bola\u00f1os-Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Borrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer F.","family":"Storb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephraim J.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.03.005_bib1","series-title":"Thomas' Hematopoietic Cell Transplantation","year":"2004"},{"key":"10.1016\/j.bbmt.2008.03.005_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MOH.0b013e328017f64d","article-title":"Alternative donor transplantation in acute myeloid leukemia: which source and when?","volume":"14","author":"Zuckerman","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","article-title":"Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma","volume":"29","author":"Anasetti","year":"1990","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood-2003-02-0430","article-title":"Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)","volume":"102","author":"Kanda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/00007890-198743060-00014","article-title":"Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes","volume":"43","author":"Kernan","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.03.005_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V68.3.770.770","article-title":"Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease","volume":"68","author":"Kernan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib10","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1704391","article-title":"Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients","volume":"33","author":"Mehta","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bcmd.2004.08.017","article-title":"Long-term outcome after haploidentical stem cell transplantation in children","volume":"33","author":"Lang","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bbmt.2008.03.005_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bcmd.2004.08.009","article-title":"Facilitating T-cell immune reconstitution after haploidentical transplantation in adults","volume":"33","author":"Waller","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bbmt.2008.03.005_bib14","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2141.2006.06300.x","article-title":"Current status of haploidentical stem cell transplantation","volume":"135","author":"Dey","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib16","first-page":"473","article-title":"Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration","volume":"13","author":"Lehnert","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0171-2985(96)80033-7","article-title":"Cyclophosphamide-induced immunological tolerance: an overview","volume":"195","author":"Mayumi","year":"1996","journal-title":"Immunobiology"},{"key":"10.1016\/j.bbmt.2008.03.005_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00007890-198708000-00021","article-title":"Drug-induced tolerance to allografts in mice. XII. The relationships between tolerance, chimerism, and graft-versus-host disease","volume":"44","author":"Mayumi","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.03.005_bib19","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood.V98.12.3456","article-title":"Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide","volume":"98","author":"Luznik","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/bbmt.2002.v8.pm11939602","article-title":"Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation","volume":"8","author":"Luznik","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib22","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"Niederwieser","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib24","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.149.8.2668","article-title":"Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A","volume":"149","author":"Nomoto","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-4608(99)00245-9","article-title":"Interphase FISH for Y chromosome, VNTR polymorphisms, and RT-PCR for BCR-ABL in the monitoring of HLA-matched and mismatched transplants","volume":"120","author":"Crescenzi","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bbmt.2008.03.005_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.8484121","article-title":"Clues to the pathogenesis of familial colorectal cancer","volume":"260","author":"Aaltonen","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2008.03.005_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ajcp\/107.3.292","article-title":"The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting","volume":"107","author":"Sreenan","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0272-2712(18)30083-0","article-title":"Bone marrow engraftment analysis after allogeneic bone marrow transplantation","volume":"20","author":"Van Deerlin","year":"2000","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib29","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib30","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2008.03.005_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc (B)"},{"key":"10.1016\/j.bbmt.2008.03.005_bib34","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","article-title":"Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study","volume":"99","author":"Junghanss","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib35","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.03.005_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2008.03.005_bib37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib38","first-page":"2004","article-title":"Outcomes for reduced intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the chronic leukemia working party of the EBMT","author":"Crawley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib39","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJMoa065464","article-title":"A Comparison of allografting with autografting for newly diagnosed myeloma","volume":"356","author":"Bruno","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib40","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbmt.2007.03.011","article-title":"Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program","volume":"13","author":"Giralt","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib41","first-page":"327","article-title":"A comparison of the effects of selected cytotoxic agents on allogeneic skin graft survival in rats","volume":"116","author":"Santos","year":"1965","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.bbmt.2008.03.005_bib42","doi-asserted-by":"crossref","unstructured":"Berenbaum MC. Prolongation of homograft survival in mice with single doses of cyclophosphamide. Nature 200, 84. 1963.","DOI":"10.1038\/200084a0"},{"key":"10.1016\/j.bbmt.2008.03.005_bib43","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.4049\/jimmunol.155.9.4179","article-title":"A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers","volume":"155","author":"Colson","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00007890-197104000-00004","article-title":"The effect of cytotoxic drugs on graft-versus-host disease in mice","volume":"11","author":"Owens","year":"1971","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.03.005_bib45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00007890-197203000-00016","article-title":"Chemotherapy of established graft-versus-host disease in mice","volume":"13","author":"Glucksberg","year":"1972","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.03.005_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00007890-197008000-00003","article-title":"Treatment of canine graft-versus-host disease with methotrexate and cyclo-phosphamide following bone marrow transplantation from histoincompatible donors","volume":"10","author":"Storb","year":"1970","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.03.005_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-0012.1987.tb00685.x","article-title":"Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: a randomized, double-blind study in patients undergoing allogeneic marrow transplantation","volume":"1","author":"Santos","year":"1987","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib48","first-page":"363","article-title":"Drug-induced tolerance to allografts in mice. VII. Optimal protocol and mechanism of cyclophosphamide-induced tolerance in an H-2 haplotype-identical strain combination","volume":"18","author":"Mayumi","year":"1986","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2008.03.005_bib49","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1073\/pnas.96.6.3120","article-title":"In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells","volume":"96","author":"Cheshier","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2008.03.005_bib50","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood.V85.10.2742.bloodjournal85102742","article-title":"Assessment of aldehyde dehydrogenase in viable cells","volume":"85","author":"Jones","year":"1995","journal-title":"Blood"},{"issue":"Suppl.","key":"10.1016\/j.bbmt.2008.03.005_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2006.12.008","article-title":"Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloablative HLA matched related and unrelated bone marrow transplantation (BMT)","volume":"13","author":"Luznik","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.03.005_bib52","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1182\/blood-2005-06-2217","article-title":"Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation","volume":"106","author":"Giaccone","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib53","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","article-title":"Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation","volume":"353","author":"Sykes","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2008.03.005_bib54","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/01.TP.0000064211.23536.AD","article-title":"Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies","volume":"75","author":"Spitzer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2008.03.005_bib55","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2006.07.0953","article-title":"Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution","volume":"25","author":"Rizzieri","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.03.005_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","article-title":"Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib57","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib58","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.03.005_bib59","first-page":"223","article-title":"Unrelated cord blood transplants in adults with hematologic malignancies","volume":"91","author":"Arcese","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2008.03.005_bib60","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib61","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1158\/1078-0432.CCR-03-0754","article-title":"Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases","volume":"10","author":"Miyakoshi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2008.03.005_bib62","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib63","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2002-11-3337","article-title":"Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning","volume":"102","author":"Barker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.03.005_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity umbilical cord blood transplantation in adults","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:31:46Z","timestamp":1761057106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1083879108001146"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718874812.793499760","asserted-by":"object"}]},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}